Shirley H Lomeli

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Signaling Pathway

Top Venues

Cancer discovery

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang, Raymond J Lim, Camelia Dumitras, Philip O Scumpia, Steven M Dubinett, Gatien Moriceau, Douglas B Johnson, Stergios J Moschos, Roger S Lo
Multi-organ landscape of therapy-resistant melanoma. Nature medicine 29 (5) (2023)
Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang, Raymond J Lim, Camelia Dumitras, Philip O Scumpia, Steven M Dubinett, Gatien Moriceau, Douglas B Johnson, Stergios J Moschos, Roger S Lo
Multi-organ landscape of therapy-resistant melanoma. Nature medicine (2023)
Prashanthi Dharanipragada, Xiao Zhang, Sixue Liu, Shirley H Lomeli, Aayoung Hong, Yan Wang, Zhentao Yang, Kara Z Lo, Agustin Vega-Crespo, Antoni Ribas, Stergios J Moschos, Gatien Moriceau, Roger S Lo
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. Cancer discovery (2023)
Zhentao Yang, Yan Wang, Sixue Liu, Weixian Deng, Shirley H Lomeli, Gatien Moriceau, James Akira Wohlschlegel, Marco Piva, Roger S Lo
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired Resistance. Cancer discovery 12 (8) (2022)
Kai Song, Jenna K Minami, Arthur Huang, Siavash R Dehkordi, Shirley H Lomeli, Jens Luebeck, Mark H Goodman, Gatien Moriceau, Oscar Krijgsman, Prashanthi Dharanipragada, Trevor Ridgley, William P Crosson, Jesus Salazar, Eli Pazol, Gabriel Karin, Rachana Jayaraman, Nikolas G Balanis, Salwan Alhani, Kyle Sheu, Johanna Ten Hoeve, Amelia Palermo, Stephen E Motika, T Niroshi Senaratne, Kim H Paraiso, Paul J Hergenrother, P Nagesh Rao, Asha S Multani, Daniel S Peeper, Vineet Bafna, Roger S Lo, Thomas Glen Graeber
Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges. Cancer discovery 12 (4) (2022)